Yinfeng Kang

Title: Yinfeng Kang: Innovator in Nanoparticle Technology

Introduction

Yinfeng Kang is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of nanoparticle technology, particularly in relation to the Epstein-Barr virus (EBV). His innovative work has led to the development of a unique self-assembled nanoparticle that holds promise for medical applications.

Latest Patents

Yinfeng Kang holds a patent for a "Self-assembled nanoparticle containing gB protein of EB virus and preparation method and use thereof." This invention relates to a self-assembled nanoparticle that includes a gB protein of the EB virus. The nanoparticle comprises a first polypeptide and a second polypeptide, with the first polypeptide containing the gB protein and a first vector subunit, while the second polypeptide includes a second vector subunit. Notably, the gB protein is displayed on the surface of the nanoparticle for the first time. The self-assembled nanoparticle exhibits a larger particle size and greater chemical stability compared to the antigen gB, along with enhanced binding capacity with neutralizing antibodies.

Career Highlights

Throughout his career, Yinfeng Kang has been associated with esteemed institutions such as Sun Yat-sen University and the Sun Yat-sen University Cancer Center. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Yinfeng Kang has collaborated with notable colleagues, including Xinchun Chen and Xiangwei Kong. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Yinfeng Kang's contributions to nanoparticle technology and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to impact the field significantly, paving the way for future developments in the treatment of viral infections.